Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-26-038111
Filing Date
2026-05-26
Accepted
2026-05-26 16:26:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A a05-26x26defa14a.htm DEFA14A 49010
2 PACIRA BIOSCIENCES LOGO pacirabiosciencestmjpega.jpg GRAPHIC 1171040
  Complete submission text file 0001628280-26-038111.txt   1598813
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35060 | Film No.: 261020304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)